Last Close
Jan 27  •  04:00PM ET
4.25
Dollar change
-0.14
Percentage change
-3.19
%
Index- P/E- EPS (ttm)-13.39 Insider Own22.55% Shs Outstand1.17M Perf Week-10.15%
Market Cap4.96M Forward P/E- EPS next Y-4.62 Insider Trans0.00% Shs Float0.90M Perf Month-16.67%
Enterprise Value4.70M PEG- EPS next Q-1.23 Inst Own1.12% Short Float6.48% Perf Quarter-15.00%
Income-8.01M P/S- EPS this Y88.43% Inst Trans2.98% Short Ratio1.01 Perf Half Y-33.07%
Sales0.00M P/B19.51 EPS next Y29.89% ROA-154.83% Short Interest0.06M Perf YTD-6.18%
Book/sh0.22 P/C6.27 EPS next 5Y- ROE-236.34% 52W High11.96 -64.46% Perf Year-24.51%
Cash/sh0.68 P/FCF- EPS past 3/5Y81.97% 76.64% ROIC-1409.93% 52W Low2.90 46.55% Perf 3Y-99.95%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.94% 6.48% Perf 5Y-99.99%
Dividend TTM- EV/Sales- EPS Y/Y TTM98.86% Oper. Margin- ATR (14)0.37 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.31 Sales Y/Y TTM- Profit Margin- RSI (14)40.10 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.31 EPS Q/Q99.37% SMA20-6.82% Beta0.02 Target Price30.00
Payout- Debt/Eq3.12 Sales Q/Q- SMA50-18.25% Rel Volume0.23 Prev Close4.39
Employees21 LT Debt/Eq2.35 EarningsNov 17 BMO SMA200-13.78% Avg Volume57.53K Price4.25
IPOJun 30, 2017 Option/ShortNo / Yes EPS/Sales Surpr.-7.69% - Trades Volume13,346 Change-3.19%
Dec-04-25 08:00AM
Nov-20-25 08:00AM
Nov-17-25 08:00AM
Nov-14-25 09:25AM
Oct-23-25 08:00AM
08:57AM Loading…
Oct-16-25 08:57AM
Oct-13-25 08:14AM
08:00AM
Aug-14-25 04:05PM
Jun-16-25 08:00AM
May-15-25 04:05PM
Mar-31-25 08:05AM
08:00AM
Jan-28-25 12:00PM
Nov-22-24 08:00AM
09:24AM Loading…
Nov-15-24 09:24AM
Nov-12-24 08:00AM
Nov-06-24 08:00AM
Oct-22-24 08:00AM
Aug-28-24 04:17PM
Aug-22-24 04:14PM
Aug-16-24 08:00AM
Aug-13-24 04:05PM
08:00AM
Aug-07-24 08:00AM
Jun-17-24 08:11AM
07:40AM
Jun-05-24 07:35AM
Jun-04-24 09:21AM
May-20-24 08:00AM
03:10AM Loading…
May-15-24 03:10AM
May-14-24 04:05PM
May-07-24 08:00AM
May-02-24 08:00AM
Apr-01-24 09:59AM
Mar-29-24 06:21AM
Mar-28-24 08:53PM
04:05PM
Mar-21-24 08:00AM
Feb-27-24 08:00AM
Feb-21-24 08:00AM
Feb-14-24 08:30AM
Nov-29-23 08:00AM
Nov-27-23 08:00AM
Nov-15-23 01:23PM
Nov-14-23 04:05PM
Nov-08-23 08:00AM
Nov-07-23 04:05PM
Nov-06-23 08:00AM
Sep-07-23 08:00AM
Aug-30-23 08:00AM
Aug-23-23 08:00AM
Aug-20-23 11:20AM
Aug-15-23 06:49AM
Aug-14-23 04:05PM
01:30PM
Aug-01-23 08:00AM
Jul-12-23 05:15PM
03:27PM
02:42PM
02:01PM
12:31PM
10:30AM
09:42AM
07:05AM
Jul-06-23 04:45PM
Jun-07-23 08:00AM
May-15-23 04:05PM
May-04-23 08:00AM
May-02-23 04:01PM
Apr-28-23 08:00AM
Mar-17-23 05:00AM
Mar-15-23 10:32AM
Mar-14-23 04:05PM
Mar-07-23 04:05PM
Dec-08-22 09:55AM
Dec-05-22 08:00AM
Nov-14-22 04:05PM
Nov-09-22 08:00AM
Oct-25-22 08:00AM
Oct-04-22 08:00AM
Sep-29-22 04:05PM
Sep-06-22 08:00AM
Aug-24-22 08:40AM
Aug-15-22 04:30PM
04:05PM
Aug-08-22 10:16AM
Aug-04-22 08:00AM
Aug-02-22 08:00AM
Aug-01-22 08:00AM
Jul-11-22 08:00AM
Jun-28-22 08:00AM
Jun-08-22 08:00AM
May-25-22 08:00AM
May-16-22 08:00AM
May-12-22 04:05PM
May-10-22 08:00AM
May-02-22 08:00AM
Apr-21-22 08:00AM
Mar-31-22 08:00AM
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.